MRK Stock Analysis: Merck & Co Inc
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health
- Latest close
- $145.31
- 20-day change
- -3.04%
- Trend state
- LEAN BULL
- Classification
- Healthcare · Drug Manufacturers - General
Market context
Merck & Co Inc moved -3.04% over the latest 20-session window. BullRecon currently classifies the broader setup as LEAN BULL.
Latest report
The latest cached company filing period (FY2025 · $65B revenue · $18.3B net income) is used alongside annual and quarterly history. Values remain tied to their reported period.
Six-dimension read
Profitability is currently the strongest dimension at 5.3/6, while Future is the lowest at 2.9/6. Scores are comparative research signals, not forecasts.